does tirzepatide cause gout and change in uric acid and its association with weight reduction: post hoc analyses of the SURMOUNT-1 randomised placebo-controlled trial GLP-1 weight loss drugs could

Since Mounjaro is approved for type 2 diabetesnot weight loss nearly all plans wont cover it when prescribed solely for weight management, even if weight loss coverage is a part of the plan

Wegovy uses the same molecule but recently received FDA approval for doses up to 7.2mg weekly, specifically for weight management

Many participants in patient forums recount losing 15% or more of their initial body weight within a year of starting tirzepatide

This review covers what the brand claims, what published research actually supports, and - most importantly - the two specific things almost every other review in this space skips

You are unable to drink enough fluids to stay hydrated